AnalyzeDirect

Regan FM, Williams RM, McDonald A, Umpleby AM, Acerini CL, O’Rahilly S, Hovorka R, Semple RK, Dunger DB. Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. J Clin Endocrinol Metab. May 2010;95(5):2113-2122.

Full Text – Open Access

Publication Date
May 2010

How Analyze was Used
“T1-Weighted transaxial scans of the abdominal region using 16 slices with slice thickness of 10 mm were obtained, and intraabdominal and sc fat areas were determined using the software Analyze (AnalyzeDirect, Stilwell, KS).”

Keywords
Acanthosis Nigricans/drug therapy
Adolescent
Adult
Body Mass Index
Breast/anatomy & histology
Child, Preschool
Female
Hemoglobin A, Glycosylated/drug effects/metabolism
Humans
Insulin Resistance/genetics
Insulin-Like Growth Factor Binding Protein 3/therapeutic use
Insulin-Like Growth Factor I/metabolism/therapeutic use
Mutation
Puberty
Receptor, Insulin/genetics
Recombinant Proteins/therapeutic use

Author Affiliation(s)
University of Cambridge, Department of Pediatrics, Cambridge, UK. (FMR, RMW)

ID# 1076

Tags: Acanthosis Nigricans/drug therapy, Adolescent, Adult, Body Mass Index, Breast/anatomy & histology, Female, Glycosylated Hemoglobin A/drug effects/metabolism, Humans, Insulin Receptor/genetics, Insulin Resistance/genetics, Insulin-Like Growth Factor Binding Protein 3/therapeutic use, Insulin-Like Growth Factor I/metabolism/therapeutic use, Mutation, Preschool Child, Puberty, Recombinant Proteins/therapeutic use